Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

NCT: NCT06183684 · RECRUITING

NCT IDNCT06183684
StatusRECRUITING
Start Date2024-02-19
Completion2032-12
SponsorLaplace Interventional, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Frequently Asked Questions

What is Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System?

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System is a clinical trial registered under NCT06183684. Current status: RECRUITING.

What is the status of NCT06183684?

The current status of NCT06183684 (Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System) is: RECRUITING.

When did Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System start?

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System started on 2024-02-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑